Cardiff Oncology, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| COMMODORE CAPITAL LP | 02/14/2025 | 5.38 M | $23.37 M | 100.00% | 11.49% |
| BLACKROCK, INC. | 02/07/2025 | 2.84 M | $12.33 M | 3.85% | 6.06% |
| PFIZER INC | 02/14/2025 | 2.41 M | $10.47 M | 100.00% | 5.15% |
| VANGUARD GROUP INC | 02/11/2025 | 2.28 M | $9.92 M | 5.23% | 4.88% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 1.54 M | $6.68 M | 100.00% | 3.28% |
| 02/14/2025 | 1.44 M | $6.26 M | 100.00% | 3.08% | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 1.29 M | $5.61 M | 100.00% | 2.76% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 982,878 | $4.27 M | 5.89% | 2.10% |
| MAI CAPITAL MANAGEMENT | 02/14/2025 | 916,587 | $3.98 M | 38.17% | 1.96% |
| STATE STREET CORP | 02/14/2025 | 848,579 | $3.68 M | 1.91% | 1.81% |
| UBS GROUP AG | 02/14/2025 | 633,000 | $2.75 M | 0.00% | 1.35% |
| NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 586,616 | $2.55 M | 73.68% | 1.25% |
| LAURION CAPITAL MANAGEMENT LP | 02/14/2025 | 576,924 | $2.50 M | 100.00% | 1.23% |
| MORGAN STANLEY | 02/14/2025 | 542,389 | $2.35 M | 8.88% | 1.16% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 508,438 | $2.21 M | 100.00% | 1.08% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 483,090 | $2.10 M | -19.80% | 1.03% |
| IKARIAN CAPITAL, LLC | 02/14/2025 | 450,000 | $1.95 M | 100.00% | 0.96% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 440,944 | $1.91 M | 188.79% | 0.94% |
| GSA CAPITAL PARTNERS LLP | 02/07/2025 | 380,070 | $1.65 M | 103.63% | 0.81% |
| NORTHERN TRUST CORP | 02/14/2025 | 337,092 | $1.46 M | 8.88% | 0.72% |
| BANK OF NEW YORK MELLON CORP | 02/04/2025 | 288,615 | $1.25 M | 68.68% | 0.62% |
| UBS GROUP AG | 02/14/2025 | 283,352 | $1.23 M | 483.46% | 0.60% |
| BLAIR WILLIAM & CO/IL | 02/12/2025 | 282,025 | $1.22 M | 14.14% | 0.60% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 258,642 | $1.12 M | 100.00% | 0.55% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 153,034 | $664,168 | 62.84% | 0.33% |
| AVESTAR CAPITAL, LLC | 01/29/2025 | 140,469 | $609,635 | 0.00% | 0.30% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 02/14/2025 | 139,854 | $606,966 | 100.00% | 0.30% |
| BOOTHBAY FUND MANAGEMENT, LLC | 02/14/2025 | 129,960 | $564,026 | 100.00% | 0.28% |
| CITADEL ADVISORS LLC | 02/14/2025 | 127,900 | $555,086 | 2,067.80% | 0.27% |
| AWM INVESTMENT COMPANY, INC. | 02/18/2025 | 106,435 | $461,928 | 100.00% | 0.23% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2025 | 105,227 | $456,685 | -42.99% | 0.22% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 101,664 | $441,222 | -16.18% | 0.22% |
| CALLAN CAPITAL, LLC | 02/03/2025 | 101,575 | $440,836 | 11.05% | 0.22% |
| CITADEL ADVISORS LLC | 02/14/2025 | 89,600 | $388,864 | 238.11% | 0.19% |
| CITADEL ADVISORS LLC | 02/14/2025 | 69,353 | $300,992 | 37.21% | 0.15% |
| DIMENSIONAL FUND ADVISORS LP | 02/13/2025 | 68,479 | $297,199 | 0.00% | 0.15% |
| ASSENAGON ASSET MANAGEMENT S.A. | 01/14/2025 | 67,231 | $291,783 | -75.15% | 0.14% |
| ROYAL BANK OF CANADA | 02/14/2025 | 65,886 | $286,000 | 1,127.61% | 0.14% |
| MARSHALL WACE, LLP | 02/13/2025 | 62,600 | $271,683 | -56.23% | 0.13% |
| BARCLAYS PLC | 02/13/2025 | 62,596 | $272,000 | 17.91% | 0.13% |
| CREATIVE PLANNING | 02/14/2025 | 60,968 | $264,602 | 13.81% | 0.13% |
| AMERICAN CENTURY COMPANIES INC | 02/11/2025 | 53,955 | $234,165 | 12.84% | 0.12% |
| RHUMBLINE ADVISERS | 01/30/2025 | 53,172 | $230,761 | 24.00% | 0.11% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 02/14/2025 | 51,190 | $222,165 | 0.00% | 0.11% |
| VIRTU FINANCIAL LLC | 02/11/2025 | 51,181 | $222,000 | 100.00% | 0.11% |
| JANE STREET GROUP, LLC | 02/14/2025 | 49,900 | $216,566 | 100.00% | 0.11% |
| DEUTSCHE BANK AG\ | 02/14/2025 | 49,566 | $215,116 | 100.00% | 0.11% |
| J. GOLDMAN & CO LP | 02/14/2025 | 47,250 | $205,065 | 100.00% | 0.10% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 45,000 | $195,300 | 23.29% | 0.10% |
| BLACKSTONE INC. | 02/14/2025 | 41,700 | $180,978 | 100.00% | 0.09% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Cardiff Oncology, Inc. institutional Ownership - FAQ's
During the previous two years, 114 institutional investors and hedge funds held shares of Cardiff Oncology, Inc.. The most heavily invested institutionals were:
COMMODORE CAPITAL LP: 5.38 M
BlackRock, Inc.: 2.84 M
PFIZER INC: 2.41 M
VANGUARD GROUP INC: 2.28 M
ORBIMED ADVISORS LLC: 1.54 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 1.29 M
59.89% of Cardiff Oncology, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 29.72 M shares in the last 24 months. This purchase volume represents approximately $87.96 M in transactions.